Trigen GmbH
Records under this name other than patents Trigen GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,514,543 | Polynucleotides encoding immunoadhesins comprising a glycoprotein VI domain Formerly held Term ended Term ended May 10, 2024 · From the USPTO record | Term ended | Term ended May 10, 2024 | From the USPTO record |
| US 7,531,178 | Immunoadhesin comprising a glycoprotein VI domain Formerly held Term ended Term ended Jan 20, 2024 · From the USPTO record | Term ended | Term ended Jan 20, 2024 | From the USPTO record |
| US 7,112,572 | Multivalent metal salts of boronic acids Lapsed on the fee record Ended Sep 26, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2014 | From the USPTO record |
| US 6,350,731 | Platelet-derived growth factor analogues Lapsed on the fee record Ended Feb 26, 2014 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2014 | From the USPTO record |
| US 7,371,729 | Boronic acid salts useful in parenteral formulations Lapsed on the fee record Ended May 13, 2012 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2012 | From the USPTO record |
| US 6,387,881 | Inhibitors and substrates of thrombin Lapsed on the fee record Ended May 14, 2010 · From the USPTO record | Lapsed on the fee record | Ended May 14, 2010 | From the USPTO record |
| US 6,313,096 | Inhibitors of trypsin-like enzymes Lapsed on the fee record Ended Nov 6, 2009 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2009 | From the USPTO record |
| US 6,114,308 | Inhibitors of trypsin-like enzymes Lapsed on the fee record Ended Sep 5, 2008 · From the USPTO record | Lapsed on the fee record | Ended Sep 5, 2008 | From the USPTO record |
| US 6,451,976 | Bi-or multifunctional molecules based on a dendroaspin scaffold Lapsed on the fee record Ended Sep 17, 2006 · From the USPTO record | Lapsed on the fee record | Ended Sep 17, 2006 | From the USPTO record |
| US 6,127,340 | Serine protease inhibitors Lapsed on the fee record Ended Oct 3, 2004 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2004 | From the USPTO record |